SPECTRUM PHARMACEUTICALS INC Deferred Compensation Liability, Classified, Noncurrent
SPECTRUM PHARMACEUTICALS INC had Deferred Compensation Liability, Classified, Noncurrent of $6.44 million as of 2020-03-31, per its 10-Q filed 2020-05-07.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent · last filed 2020-05-07
- 2020-03-31: Deferred Compensation Liability, Classified, Noncurrent $6.44M.
- 2019-12-31: Deferred Compensation Liability, Classified, Noncurrent $8.60M.
- 2019-09-30: Deferred Compensation Liability, Classified, Noncurrent $7.71M.
- 2019-06-30: Deferred Compensation Liability, Classified, Noncurrent $7.32M.
| Period end | Deferred Compensation Liability, Classified, Noncurrent |
|---|---|
| 2020-03-31 | $6.44M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $8.60M 10-Q · filed 2020-05-07 |
| 2019-09-30 | $7.71M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $7.32M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $6.50M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $5.47M 10-K · filed 2020-03-02 |
| 2018-09-30 | $5.76M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $5.21M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $5.98M 10-Q · filed 2018-05-04 |
| 2017-12-31 | $5.93M 10-K · filed 2019-02-28 |
| 2017-09-30 | $10.25M 10-Q · filed 2017-11-03 |
| 2017-06-30 | $9.55M 10-Q · filed 2017-08-04 |
| 2017-03-31 | $8.94M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $8.35M 10-K · filed 2018-03-07 |
| 2016-09-30 | $7.80M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $7.67M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $7.12M 10-Q · filed 2016-05-06 |
| 2015-12-31 | $6.46M 10-K · filed 2017-03-14 |
| 2015-09-30 | $5.96M 10-Q · filed 2015-11-06 |
| 2015-06-30 | $5.99M 10-Q · filed 2015-08-07 |
| 2015-03-31 | $5.59M 10-Q · filed 2015-05-08 |
| 2014-12-31 | $4.69M 10-K · filed 2016-03-14 |
| 2014-09-30 | $4.72M 10-Q · filed 2014-11-10 |
| 2014-06-30 | $4.53M 10-Q · filed 2014-08-08 |
| 2014-03-31 | $4.00M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $3.95M 10-K · filed 2015-03-13 |
| 2012-12-31 | $2.37M 10-K · filed 2014-03-12 |